chloride ions was about 25% less than that for HbA or HbS are hindered by the lack of quantitative information on the and is ascribed to the introduction of a new positive charge extent of participation of different amino acid residues in near one of the major oxygen-linked chloride binding sites the aggregation process. One such site is Asp-85(a), which of hemoglobin. The gelation concentration of the double is involved in a parallel interdouble strand ionic interaction mutant was measured by a new procedure (Bookchin et al, with Lys-144(b) according to the crystal structure of HbS, but 1994); the maximal amount of soluble hemoglobin (C sat ) in electron microscopy does not specifically show Asp-85(a) as the presence of dextran indicated a decreased tendency for a contact site for fiber formation. Using a yeast recombinant gelation with a C sat of 53 mg/mL compared with 34 mg/mL system, we have substituted this site by Lys to abolish ion for HbS. This inhibitory effect is smaller than that of the pairing and to make a quantitative determination of its par-E6V(b)/L88A(b) (C sat , 67 mg/mL) and the E6V(b)/K95I(b) ticipation in aggregation. The purified double mutant was (C sat , 90 mg/mL) recombinant hemoglobins. Thus, we would shown to have the expected pI, the calculated molecular classify Asp-85(a) as a moderate contributor to the strength weight, correct amino acid composition, and peptide map.
T mutants or that cannot be modified by chemical procedures. HE PRIMARY CAUSE for sickle cell anemia has been known since 1956 when Ingram 1 showed that the difIndeed, results obtained with both natural and recombinant ference in electrophoretic behavior between HbS and HbA Hbs might resolve differences between models of the HbS described by Pauling et al 2 was due to the replacement of a polymer. 7, 8 single amino acid, ie, Glu r Val at position 6 of the bMost of the earlier work with the recombinant Hb system chain E6V(b). This point mutation leads to the initial strong focused on the sites at or near the hydrophobic pocket of hydrophobic interaction between the adjacent Hb tetramers the beta chain, which is the acceptor for the mutated Val as described in detail by Bunn and Forget. 3 The subsequent residue. [18] [19] [20] Recently, we showed that a residue located at formation of long Hb fibers involves many sites of contact the exterior of the Hb tetramer, (Lys-95 [b] ), 21 reduces the as deduced initially from the effects of natural Hb mutants gelation nearly twice as much as a residue in the hydrophobic with substitutions at other sites on the polymerization of pocket, ). 20 This finding was in agreement with HbS 4 and subsequently from the x-ray structure 5, 6 and also the electron microscopy studies, 8 but not with the crystal by electron microscopy, 7,8 although differences in interpretastructure of HbS, 6 which shows no contacts between Lystion of these models persist. Because this structural informa-95(b) and the amino acid side chains of adjacent tetramers. tion is available, it is now feasible to study the overall Because the Lys-95(b) site is on the exterior of the Hb strength of various sites in sickle hemoglobin aggregates. 9, 10 tetramer, it is a potentially accessible site for compounds to An alternate approach, ie, chemical modification has probe targeted for inhibiting gelation, whereas the residues at vided information about the extent of participation of other the hydrophobic pocket are buried within the Hb tetramer amino acid residues in the aggregation process.
11-15 However, and hence not likely candidates. with this approach there are many sites that are not accessible
The studies presented in this report represent a continuato a given reagent. More recently, the use of recombinant tion of a systematic effort that we initiated recently emHb 16, 17 has provided the advantage that any amino acid subploying a yeast expression system for producing recombinant stitution can be made at sites not represented by the natural HbS double mutants. 20, 21 These recombinant hemoglobins, which have been characterized by a number of biochemical criteria, are being used to obtain quantitative information on chloromethylketone (TPCK)-treated trypsin, dextran, diphosphoglycerate (DPG), and inositol hexaphosphate (IHP) were purchased from Sigma (St Louis, MO). pBluescript II SK(/) was from Stratagene (La Jolla, CA). The construction of pGS189 and pGS389 plasmids is described elsewhere. 16, 21 All other reagents were of analytical purity.
Site-directed mutagenesis. To prepare the E6V/D85K(a) mutant, we first inserted the a-globin-coding gene from pGS189 to pBluescript II SK(/) as a Sal I fragment. This fragment contains the full-length human a-globin cDNA under transcriptional control of a pGGAP promoter. The modified plasmid (pSK[/]a) was transformed in Escherichia coli BW313, and the uridine-containing single-stranded DNA was isolated from the supernatant of the bacterial culture after infecting the cells with M13KO7 helper phage. The oligonucleotide 5-GTGCGCGTGCAGCTTGCTCAGGGCGGA-3 was used to create the Asp-85 r Lys mutation by the method of Kunkel. 25 The underlined bases are those used to create the desired mutation. The presence of the mutation was sought by screening with partial sequencing of the mutation site. The mutated a-globin region was subcloned into pGS189 sickle , which contains the native a-globin and the 6(b)Glu r Val mutated b-globin cDNAs, 17 by digestion with BssHII and BstEII enzymes to create incompatible cohesive termini and thus to increase the percentage of the insert in correct orientation. Finally, the a-and b-globin gene cassette was isolated as a Not I fragment after digesting the newly synthesized pGS189 sickle-85(Lys) with Not I and Bgl I and inserted into pGS389 previously digested with Not I. The correct insertional direction was verified by restriction mapping and the entire a-globin gene was lithium acetate method. 26 The transformants were selected and the copy number of the plasmid was increased by growing the yeast on deoxy HbS also implicates Asp-85(a) in interdouble strand contacts, 5, 6 as it has several interactions including an ion pairing with Lys-144(b). To quantitate its role in aggregation, we replaced Asp-85(a) with Lys by site-directed mutagenesis to completely abolish its ion interaction with Lys-144(b). However, in view of a possibly unfavorable interaction between Lys-85(a) and Lys-144(b), it was of critical importance to establish that the functional integrity of the double mutant was not compromised. For measuring the gelation concentrations, we have adapted a new and sensitive procedure to make quantitative comparisons between E6V(b)/D85K(a) and previously produced HbS double mutants and to evaluate its significance as a potential target site for the development of chemical inhibitors against HbS gelation.
MATERIALS AND METHODS
Reagents and plasmids. The restriction endonucleases, T4 polynucleotide kinase, alkaline phosphatase, DNA ligase, and Gene 32 Protein, T4 were from Boehringer Mannheim (Germany). The DNA sequencing kit and the T7 DNA Polymerase (Sequenase Version 2.0) were obtained from US Biochemical Corp (Cleveland, OH). The 35 S-labeled deoxyadenosine triphosphate (dATP) was from DuPont NEN (Boston, MA). The oligonucleotides were synthesized by Analytical methods. Mass spectrometric analysis was done on a matrix-assisted laser desorption time-of-flight mass spectrometer constructed at Rockefeller University, New York, NY and described elsewhere. 27, 28 Fast Protein-Peptide-Polynucleotide Liquid Chromatography (FPLC) purification on Mono Q (Pharmacia, Uppsala, Sweden) was performed using 20 mmol/L Tris-acetate buffer, pH 8.0, and an NaCl gradient from 0 to 1 mol/L. Isoelectric focusing, amino acid analysis, and other procedures were performed as described earlier. 20, 21, 29, 30 To isolate the a-and b-globin chains, a Vydac C-4 column was equilibrated with 37.6% acetonitrile in 0.1% trifluoroacetic acid and the sample was eluted with a linear gradient of acetonitrile to 43.3%. The isolated a-globin chain was digested with trypsin, 21 and the resulting peptides were separated on a Vydac 400VHP575 strong cation exchange column by a linear gradient of NaCl in 20 mmol/L sodium acetate /10% acetonitrile, pH 5.2. a complete minimal medium first without uracil, then without uracil or leucine. To express the E6V(b)/D85K(a) mutant hemoglobin, the yeast was grown in yeast extract-peptone (YP) medium for 4 days with ethanol as the carbon source. 16 The promoter controlling the transcription of the globin genes was induced by adding 3% galactose for 20 hours before harvesting of the yeast cells. The cells Functional studies. The oxygen dissociation curves were deterkcal mol
01
) caused the mutation frequency to fall below the mined at 37ЊC on a modified Hem O Scan instrument (Aminco, detection limit when using the standard Kunkel method. 25 Silver Spring, MD) as described previously. 21, 29 Before the measureBy decreasing the oligonucleotide:template ratio to 50:3 and ments, the Hb samples were dialyzed, converted to the oxy form, 32 performing the annealing reaction at a temperature change and concentrated using CentriPrep, Centricon and MicroCon ultraof 95ЊC to 20ЊC over a period of 15 hours in the presence filtration devices (Amicon; molecular weight cut-off of 10,000). The final protein concentrations were verified by amino acid analysis on a Beckman 6300 analyzer (Palo Alto, CA). When evaluating the effects of allosteric modulators, the samples were in 50 mmol/L bisTris buffer, pH 7.4. For determining the Bohr effect, the Hb samples were first dialyzed against H 2 O, concentrated to a final concentration of 1 mmol/ L and diluted with an equivalent amount of 100 mmol/L bis-Tris buffers of different pH values before the measurement of the oxygen dissociation curves. The final pH was verified by a microelectrode (Microelectrodes Inc, Bowdoinville, ME).
Determination of C sat . The method used for determining the gelation concentration (C sat ) of Hb is based on the decrease of the solubility of HbS in the presence of dextran. 33 The E6V(b)/D85K(a) or HbS sample in the oxy form in 50 mmol/L potassium phosphate buffer, pH 7.5 was mixed with dextran (100 mg/mL final concentration). Mineral oil was then layered on top and fresh sodium dithionite solution (50 mmol/L final concentration) was added below the Hbdextran mixture anaerobically using a gas-tight syringe. The reaction mixture was incubated at 37ЊC for 30 minutes, mixed thoroughly, and centrifuged in a microcentrifuge for 30 minutes. The clear supernatant was carefully separated from the aggregated Hb and its hemoglobin concentration measured by amino acid analysis on a Beckman 6300 amino acid analyzer. The difference between the Hb concentration of the supernatant (C sat ) and the initial Hb concentration is an indication of the extent of gelling.
Molecular modeling. The molecular modeling was done on a Silicon Graphics, Inc (Mountain View, CA) Power Indigo 2 computer using the molecular modeling program Insight II (Biosym/ MSI). The coordinates of human sickle hemoglobin (1HBS) were obtained from the Brookhaven protein database.
RESULTS

Mutagenesis.
Because no a-chain HbS mutants have been produced using the yeast expression system, it was necessary to create a plasmid containing the a-globin gene. This was accomplished by taking advantage of the unique Sal I site at the multiple cloning site of pBluescript II SK(/). A Sal I fragment of the pGS189 extending downstream from the end of the b-globin gene to the end of the a-globin gene Peptide mapping. For this analysis, we took advantage of the creation of a new trypsin cleavage site at the 85-a position. Digestion of the isolated a-chain with trypsin produced the expected strongly basic pentapeptide (Leu-HisAla-His-Lys). Because a reversed phase column generally used for peptide mapping was unable to separate this peptide from the others, we used a strong cation exchanger (Vydac 400VHP575) for this purpose. At pH 5, the pentapeptide has a net charge of /3 and separated as shown in Fig 3. In comparison, the chromatogram obtained using the a-chain of HbS lacked this peak. This pentapeptide was collected and it had the expected amino acid composition (Table 1) .
Functional properties. The oxygen binding properties of E6V(b)/D85K(a) were determined under various conditions. In the absence of added chloride, the double mutant showed a typical sigmoidal oxygen equilibrium curve (Fig 4) . The P 50 value was 10, which is the same as that for HbA, HbS, of chloride ions, its P 50 value gradually increased to a maxi- the P 50 value of the double mutant D95K was also tested Purification. After subcloning the mutated DNA frag- (Table 2) . Although the results in Table 2 show some variment into pGS389, which contains the human a-and bability with each Hb, with either allosteric effector the ratio globin cDNAs, the sickle hemoglobin double mutant, of effector:Hb concentrations at the point of maximum effect E6V(b)/D85K(a) was expressed in yeast as described in was close to one for both the E6V(b)/D85K(a) mutant and Materials and Methods. On a CM-Cellulose 52 column, it HbS. The Hill coefficients of E6V(b)/D85K(a) in the presadhered more avidly than HbS, as expected for a mutant ence of various concentrations of chloride or DPG varied having an Asp to Lys surface mutation. For elution, a gradibetween 2.3 and 2.8. Thus, the double mutant showed full ent of up to 25.5 mmol/L potassium phosphate instead of cooperativity. Small conformational changes in these recom-15 mmol/L used for HbS 17 was required. binant Hbs cannot be rigorously excluded. However, a careThe purified hemoglobin was rechromatographed on ful circular dichroism study of another HbS double mutant 20 Mono Q column from which it eluted as a single peak (Fig  did not show evidence for such an effect.
1) without any indication of multiple forms of recombinant
Tetramer-dimer dissociation constant. The tetramer-dihemoglobin reported earlier by others.
35,36 Isoelectric focusmer dissociation constant for the liganded recombinant ing (Fig 2) of the purified E6V(b)/D85K(a) indicated an E6V(b)/D85K(a) was found to be 2.1 { 0.2 mmol/L. This isoelectric point (pI)-value close to 8.0.
value is slightly higher than the 0.7 { 0.2 mmol/L found for Mass spectrometry. Matrix-assisted laser desorption HbS, but because it is much less than the Hb concentration mass spectrometry was used to verify the molecular masses (500 mmol/L to -2 mmol/L) used for the functional studies of the a-and b-globin chains of the purified Hb double such as the oxygen binding curve, the Bohr effect and the mutant. The molecular mass (15,140.3) obtained for the agelation studies, the double mutant was predominantly tetrachain by a time-of-flight method agrees well with the theoretmeric during these measurements. ical value of 15,139.5 mass units for the mutant a-chain.
Bohr effect. When the pH was increased from 6.8 to 7.4, The difference of 13.9 mass units between the measured the P 50 of the double mutant and of HbA decreased from value and the calculated value of a wild-type a-chain of 18.2 to 9.0. ( Fig 5) . This value was calculated to be 00.34 (correlation showed that the recombinant sickle hemoglobin produced in the yeast expression system is indistinguishable by a number coefficient, r Å .994) for E6V(b)/D85K(a), which agrees reasonably well with the value of 00.41 (r Å .995) obtained of chemical and biochemical assays from native HbS isolated from human red blood cells. 29 The misfolding of hemoglobin for HbA.
reported for the E coli expression 39 is not apparent for the Gelation. The gelation concentration of E6V(b)/ hemoglobin expressed in yeast by any of the criteria that we D85K(a) was measured in the presence of 100 mg/mL of have used for characterization. The production and characdextran by the method of Bookchin et al 33 as described in terization of an E6V(b)/D85K(a) hemoglobin double mutant Materials and Methods. After incubation at 37ЊC and centrifis, to our knowledge, the first a-chain sickle Hb mutant ugation, the maximum solubility (C sat ) of HbS or of the produced using recombinant DNA technology. The mutant double mutant was obtained by measuring the Hb concentraHb was shown to have the predicted molecular mass, isoelection in the supernatant. The C sat value of E6V(b)/D85K(a) tric point, and trypsin cleavage sites. Its oxygen affinity, at three different initial Hb concentrations of 56, 64, or 127 response to DPG, Hill coefficient, and the alkaline Bohr mg/mL was between 50 and 55 mg/mL (Fig 6) . An initial effect were the same as the corresponding values for native Hb concentration of 31 mg/mL was below the C sat value and HbA. Thus, it is identical to natural HbA and HbS in these thus, no change in the Hb concentration after incubation and properties. Possible minor local changes in the orientation centrifugation was observed. The average C sat value of 53 of amino acids around the D85K(a) mutant site with respect mg/mL of E6V(b)/D85K(a) is clearly elevated compared to chloride binding are discussed below. with the value of 34 mg/mL of HbS, but much lower than
The replacement of Asp with Lys could have created the values for two other double mutants produced in our strong unfavorable contacts between the a-85 site and some laboratory and whose gelation was determined by the same positively charged residues in its vicinity and thus have had method, ie, E6V(b)/L88A(b) (67 mg/mL) and E6V(b)/ a large effect on the intratetrameric contacts and on the K95I(b) (90 mg/mL). 21 in which we showed that a replacement of Lys-95(b) with Ile causes a drastic inhibition of gelation. concentration of 0.5 mmol/L to 2 mmol/L, the extent of dimerization of the double mutant is negligible.
These results emphasize the significant differences between various ionizable surface amino acids in stabilizing the HbS The E6V(b)/D85K(a) double mutant had a slightly decreased response to chloride; in the presence of 0.5 mol/L aggregate and suggest that an appreciation of the quantitative contribution of critical amino acid side chains to the aggregaNaCl, the double mutant had a P 50 of 17 mm Hg in comparison to 21 mm Hg for HbS (ie, a 20% reduction in the oxygention process might show new and more important sites, thus prompting further consideration of developing a therapeutic linked chloride effect). Earlier studies by us and others have shown that one of the oxygen-linked chloride-binding sites modality directed at the HbS polymer itself. is located at the a-a interface in the central dyad axis of Hb ACKNOWLEDGMENT and consists predominantly of amino acids Val-1(a) and Arg-141(a). 40, 41 As shown in Fig 7, 111: 161, 1993 In this study, we have continued our efforts to understand 
